Micro and Macro Circulation in Sepsis
Key facts
- Who runs it
- Denver Health and Hospital Authority
- Where
- Denver, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 68 people enrolled
- Started
- 1 Jul 2022
- Ended
- 31 May 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Starling Stroke Volume (Starling SV)- Passive Leg Raise
- Microscan Sublingual Microscopy
- Venous Excess Ultrasound Scoring (VExUS)
- Urine Collection
- Record updated
- 5 December 2025
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Septic Patient Cohort:
- Greater than or equal to 18 years of age
- Diagnosed with sepsis or septic shock
- Require admission to the Hospital; Control Cohort:
- Greater than or equal to 18 years of age
- Undergoing elective surgery requiring intubation and general anesthesia
Who cannot take part
- Chronic Kidney disease on dialysis
- History of Chronic Kidney disease on dialysis, uncontrolled diabetes, cirrhosis, heart failure, or nephritic or nephrotic syndromes
- Less than 18 years old
- Less than 18 years old
- Patients with any of the following characteristics will be excluded
- Currently pregnant
- Incarcerated persons; Control Cohort:
- Currently pregnant
- Incarcerated persons
Where in United States
- Denver Health Medical CenterDenver, United States
About the trial
What the trial wants to find out
Purpose: To assess the prognostic role of Handheld Vital Microscopy (HVM) and evaluate levels of endothelial glycocalyx (eGC) breakdown in patients demonstrating Hemodynamic Incoherence (HI), to elucidate a mechanistic link between the eGC and HI in order to inform prognostic enrichment of future resuscitation trials. We will serially evaluate microhemodynamics (MiH) and macro hemodynamics (maH) and the perfused boundary region (PBR, an visual proxy for eGC thickness) using HVM, and a validated circulating biomarker of eGC integrity.
The 2 groups in the trial
- Septic Patient InterventionsOther group
Septic Patients will have all interventions performed: Urine collection, Passive Leg Raise, Ultrasound and sublingual microscopy
Treatment: Starling Stroke Volume (Starling SV)- Passive Leg Raise, Microscan Sublingual Microscopy, Venous Excess Ultrasound Scoring (VExUS), and Urine Collection
- Control Patient InterventionsOther group
Control patients will have urine collection and sublingual microscopy performed when intubated
Treatment: Starling Stroke Volume (Starling SV)- Passive Leg Raise and Urine Collection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Utility of Longitudinal Measurement of Hemodynamic Incoherence and Endothelial
- Record updated
- 5 December 2025